Israel
Microbot Medical is a company dedicated to creating transformational #robotic medical technologies that can change the future of medicine. Founded in 2010 and headquartered in Israel, the company's vision is to improve the quality of life of millions of patients globally by advancing robotic technologies for performing surgical procedures within the human body. Microbot Medical aims to offer physicians and their patients less invasive and more precise solutions, tapping into the rapidly growing minimal invasive space in the medical field.
The company develops robotic medical devices such as the LIBERTY® Robotic System, one&done™ ViRob™, and TipCAT™, which provide doctors and surgeons with advanced technological capabilities to improve a patient’s health, comfort, and quality of life. This dedication to innovation has attracted significant post-IPO equity investment, with a notable $2.35M investment received on 03 June 2024.
Microbot Medical's commitment to pioneering technology in the medical space positions it as an exciting prospect in the healthcare and robotics industries, with the potential to make a significant impact on patient care and surgical procedures globally. For more information, visit www.microbotmedical.com.
